GeneXpert Testing: Applications for Clinical Microbiology, Part I*

Clinical Microbiology Newsletter

Volumn 30, Issue 23, 2008, Pages 175-179

  Marlowe, Elizabeth M ^a   Wolk, Donna M ^b  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM DETECTION; CEREBROSPINAL FLUID; ENTEROVIRUS; GENETIC PROCEDURES; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; SKIN CULTURE; SOFT TISSUE; STREPTOCOCCUS AGALACTIAE;

EID: 56849104461     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2008.11.001     Document Type: Article

References (47)

1. Edwards R.K., et al. Rapid group B streptococci screening using a real-time polymerase chain reaction assay. Obstet. Gynecol. 111 (2008) 1335-1341
2. Gavino M., and Wang E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. Am. J. Obstet. Gynecol. 197 (2007) 384-388
3. Kost C.B., et al. Multicenter beta trial of the GeneXpert enterovirus assay. J. Clin. Microbiol. 45 (2007) 1081-1086
4. Marlowe E.M., et al. Performance of the GeneXpert enterovirus assay for detection of enteroviral RNA in cerebrospinal fluid. J. Clin. Virol. 43 (2008) 110-113
5. Cepheid. Xpert MRSA package insert (2007), Cepheid, Sunnyvale, CA
6. Bergeron M.G., et al. Rapid detection of group B streptococci in pregnant women at delivery. N. Engl. J. Med. 343 (2000) 175-179
7. Schrag S.J., et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N. Engl. J. Med. 347 (2002) 233-239
8. Schrag S., et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. Morb. Mortal. Wkly. Rep. Recomm. Rep. 51 (2002) 1-22
9. Schrag S.J., et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342 (2000) 15-20
10. Stapleton R.D., et al. Risk factors for group B streptococcal genitourinary tract colonization in pregnant women. Obstet. Gynecol. 106 (2005) 1246-1252
11. Annonymous. Disparities in universal prenatal screening for group B streptococcus -North Carolina, 2002-2003. MMWR Morb. Mortal. Wkly. Rep. 54 (2005) 700-703
12. Anonymous. Perinatal group B streptococcal disease after universal screening recomm endations - United States, 2003-2005. MMWR Morb. Mortal. Wkly. Rep. 56 (2007) 701-705
13. Honest H., Sharma S., and Khan K.S. Rapid tests for group B Streptococcus colonization in laboring women: a systematic review. Pediatrics 117 (2006) 1055-1066
14. Yancey M.K., et al. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet. Gynecol. 88 (1996) 811-815
15. De Cueto M., et al. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet. Gynecol. 91 (1998) 97-102
16. Davies H.D., et al. Multicenter study of a rapid molecular-based assay for the diagnosis of group B streptococcus colonization in pregnant women. Clin. Infect. Dis. 39 (2004) 1129-1135
17. Cepheid. Smart GBS assay package insert (2007), Cepheid, Sunnyvale, CA
18. Stanway G.F., et al. Picornaviridae. In: Fauquet C.M., et al. (Ed). Virus taxonomy. 8th report of the International Committee on the Taxonomy of Viruses (2005), Elsevier Academic Press, London, United Kingdom 757-778
19. Rotbart H.A. Enteroviral infections of the central nervous system. Clin. Infect. Dis. 20 (1995) 971-981
20. Rotbart H.A., et al. Clinical significance of enteroviruses in serious summer febrile illnesses of children. Pediatr. Infect. Dis. J. 18 (1999) 869-874
21. Strikas R.A., Anderson L.J., and Parker R.A. Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J. Infect. Dis. 153 (1986) 346-351
22. Ginocchio C.C., et al. Development, technical performance, and clinical evaluation of a NucliSens basic kit application for detection of enterovirus RNA in cerebrospinal fluid. J. Clin. Microbiol. 43 (2005) 2616-2623
23. Storch G.A. Central nervous System Infections. In: Storch G.A. (Ed). Essentials of diagnostic virology (2000), Churchhill Livingstone, New York 37-58
24. Capaul S.E., and Gorgievski-Hrisoho M. Detection of enterovirus RNA in cerebrospinal fluid (CSF) using NucliSens EasyQ Enterovirus assay. J. Clin. Virol. 32 (2005) 236-240
25. Lai K.K., et al. Evaluation of real-time PCR versus PCR with liquid-phase hybridization for detection of enterovirus RNA in cerebrospinal fluid. J. Clin. Microbiol. 41 (2003) 3133-3141
26. Landry M.L., Garner R., and Ferguson D. Real-time nucleic acid sequence-based amplification using molecular beacons for detection of enterovirus RNA in clinical specimens. J. Clin. Microbiol. 43 (2005) 3136-3139
27. Monpoeho S., et al. Application of a real-time polymerase chain reaction with internal positive control for detection and quantification of enterovirus in cerebrospinal fluid. Eur. J. Clin. Microbiol. Infect. Dis. 21 (2002) 532-536
28. Petitjean J., et al. Development and evaluation of a real-time RT-PCR assay on the LightCycler for the rapid detection of enterovirus in cerebrospinal fluid specimens. J. Clin. Virol. 35 (2006) 278-284
29. Silekens, P. et al. Real time NASBA for the detection of enterovirus RNA in cerebrospinal fluid, abstr. S14. Pan American Society for Clinical Virology Meeting, Clearwater, FL.
30. Verstrepen W.A., et al. Rapid detection of enterovirus RNA in cerebrospinal fluid specimens with a novel single-tube real-time reverse transcription-PCR assay. J. Clin. Microbiol. 39 (2001) 4093-4096
31. Nigrovic L.E., and Chiang V.W. Cost analysis of enteroviral polymerase chain reaction in infants with fever and cerebrospinal fluid pleocytosis. Arch. Pediatr. Adolesc. Med. 154 (2000) 817-821
32. Polage C.R., and Petti C.A. Assessment of the utility of viral culture of cerebrospinal fluid. Clin. Infect. Dis. 43 (2006) 1578-1579
33. Ramers C., et al. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 283 (2000) 2680-2685
34. Robinson C.C., et al. Impact of rapid polymerase chain reaction results on management of pediatric patients with enteroviral meningitis. Pediatr. Infect. Dis. J. 21 (2002) 283-286
35. Stellrecht K.A., et al. The impact of an enteroviral RT-PCR assay on the diagnosis of aseptic meningitis and patient management. J. Clin. Virol. 25 Suppl.1 (2002) S19-S26
36. Hamilton M.S., et al. Clinical utility of polymerase chain reaction testing for enteroviral meningitis. Pediatr. Infect. Dis. J. 18 (1999) 533-537
37. van Vliet K.E., et al. Multicenter proficiency testing of nucleic acid amplification methods for the detection of enteroviruses. J. Clin. Microbiol. 39 (2001) 3390-3392
38. Cepheid. Xpert EV package insert (2006), Cepheid, Sunnyvale, CA
39. Seme K., et al. GeneXpert enterovirus assay: one-year experience in a routine laboratory setting and evaluation on three proficiency panels. J. Clin. Microbiol. 46 (2008) 1510-1513
40. Bernard H.C., B. Starkley, and B. Yen-Lieberman. 2007. Evaluation of enterovirus detection using the GeneXpert Dx system, abstr. C-085. Abstr. 107th Gen. Meet. Am. Soc. Microbiol., American Society for Microbiology, Washington, DC.
41. Klevens R.M., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298 (2007) 1763-1771
42. Anonymous. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am. J. Infect. Control 31 (2003) 481-498
43. Edwards J.R., et al. National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2007. Am. J. Infect. Control 35 (2007) 290-301
44. Muto C.A., et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylo coccus aureus and enterococcus. Infect. Contr. Hosp. Epidemiol. 24 (2003) 362-386
45. McKibben L., et al. Ensuring rational public reporting systems for health care-associated infections: systematic literature review and evaluation recommendations. Am. J. Infect. Control 34 (2006) 142-149
46. McKibben L., et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am. J. Infect. Control 33 (2005) 217-226
47. Siegel J.D., et al. Management of multidrug-resistant organisms in health care settings, 2006. Am. J. Infect. Control 35 (2007) S165-S193